rs11047892
Variant names:
Your query was ambiguous. Multiple possible variants found:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_001001660.3(ETFRF1):c.*787T>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0996 in 215,708 control chromosomes in the GnomAD database, including 1,542 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.10 ( 1135 hom., cov: 33)
Exomes 𝑓: 0.097 ( 407 hom. )
Consequence
ETFRF1
NM_001001660.3 3_prime_UTR
NM_001001660.3 3_prime_UTR
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.00300
Publications
8 publications found
Genes affected
ETFRF1 (HGNC:27052): (electron transfer flavoprotein regulatory factor 1) Involved in respiratory electron transport chain. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]
KRAS (HGNC:6407): (KRAS proto-oncogene, GTPase) This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
KRAS Gene-Disease associations (from GenCC):
- cardiofaciocutaneous syndrome 2Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics, PanelApp Australia
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 3Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
- cardiofaciocutaneous syndromeInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
- linear nevus sebaceous syndromeInheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.136 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ETFRF1 | NM_001001660.3 | c.*787T>A | 3_prime_UTR_variant | Exon 3 of 3 | ENST00000381356.9 | NP_001001660.2 | ||
| KRAS | NM_004985.5 | c.*4696A>T | downstream_gene_variant | ENST00000311936.8 | NP_004976.2 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.101 AC: 15311AN: 152026Hom.: 1135 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
15311
AN:
152026
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0971 AC: 6171AN: 63564Hom.: 407 Cov.: 0 AF XY: 0.0972 AC XY: 2867AN XY: 29502 show subpopulations
GnomAD4 exome
AF:
AC:
6171
AN:
63564
Hom.:
Cov.:
0
AF XY:
AC XY:
2867
AN XY:
29502
show subpopulations
African (AFR)
AF:
AC:
67
AN:
2924
American (AMR)
AF:
AC:
132
AN:
1912
Ashkenazi Jewish (ASJ)
AF:
AC:
237
AN:
4040
East Asian (EAS)
AF:
AC:
3
AN:
9318
South Asian (SAS)
AF:
AC:
62
AN:
564
European-Finnish (FIN)
AF:
AC:
112
AN:
412
Middle Eastern (MID)
AF:
AC:
20
AN:
414
European-Non Finnish (NFE)
AF:
AC:
5023
AN:
38666
Other (OTH)
AF:
AC:
515
AN:
5314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.496
Heterozygous variant carriers
0
268
535
803
1070
1338
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.101 AC: 15305AN: 152144Hom.: 1135 Cov.: 33 AF XY: 0.105 AC XY: 7835AN XY: 74346 show subpopulations
GnomAD4 genome
AF:
AC:
15305
AN:
152144
Hom.:
Cov.:
33
AF XY:
AC XY:
7835
AN XY:
74346
show subpopulations
African (AFR)
AF:
AC:
927
AN:
41556
American (AMR)
AF:
AC:
1170
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
AC:
211
AN:
3470
East Asian (EAS)
AF:
AC:
11
AN:
5186
South Asian (SAS)
AF:
AC:
467
AN:
4820
European-Finnish (FIN)
AF:
AC:
2873
AN:
10570
Middle Eastern (MID)
AF:
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
AC:
9371
AN:
67940
Other (OTH)
AF:
AC:
175
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
684
1368
2051
2735
3419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
180
360
540
720
900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
137
AN:
3476
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.